The Shredder (Rad-140 + S-23) – Product Information

The Shredder is a novel research product that combines two selective androgen receptor modulators (SARMs), RAD-140 (Testolone) and S-23. This unique blend is designed for research purposes to investigate their potential synergistic effects on muscle development and performance enhancement.

The combination of RAD-140 and S-23 in The Shredder research product is intended to explore the potential synergistic effects of these two SARMs. As research compounds, they are believed to have complementary mechanisms of action that could lead to enhanced muscle development and performance.

While the specific interactions between RAD-140 and S-23 are not fully understood and may vary depending on the research context, it is hypothesized that their combined use may lead to greater anabolic effects on muscle tissue. Additionally, researchers may investigate whether the combination enhances endurance, muscle recovery, and other parameters related to performance.

• The Shredder consists of two compounds: RAD-140 and S-23.
• RAD-140 (Testolone) is offered in 33mg per ml for 30 ml, totaling 1000mg.
• S-23 SARM is offered in 33mg per ml for 30ml, totaling 1000mg.

RAD-140

Testolone, also known as RAD-140, as a research compound is being investigated for its potential ability to enhance muscle hypertrophy. Current studies are examining the preclinical characterization of selective androgen receptor modulators and anabolic activity in male cynomolgus monkeys. To assess anabolic activity, one study examined gross body weight, which we know to be a sensitive marker of anabolic androgen action in young nonhuman primates. The results on animal body weight of 28-day dosing with RAD140 were found to be statistically significant. This shows massive promise in the potential muscular gains brought on by Testolone.

S-23

According to the available studies, S-23 induced infertility in all rats it was exposed to. These effects are dose-dependent and temporary, meaning the rats regained fertility following treatment. This shows the potential of S-23 as an oral male contraceptive.

According to the research, S-23 subdues serum concentration of luteinizing hormone and follicle-stimulating hormone to produce biphasic effects on spermatogenesis. Additional research and clinical trials should be conducted to determine the efficacy and safety of S-23 as an oral contraceptive.

The above-mentioned study produced other beneficial desirable effects. For instance, researchers observed a stronger affinity to androgen receptors as compared to other popular compounds like Andarine. It also has an ideal anabolic-androgenic ratio allowing it to produce a good number of positive effects without any severe complications. One of those effects was increasing bone mineral density and lean muscle mass.

Therefore, while S-23 may be effective as a male birth control pill, it can also be used for other purposes, especially among patients with chronic conditions that lead to muscle wasting.